Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

156
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
156
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

126
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
126
Altered States of Awareness01:06

Altered States of Awareness

149
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
149
Psychosurgery01:30

Psychosurgery

46
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
46
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Modeling in Therapy01:26

Modeling in Therapy

48
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
48

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-assisted rational decision-making.

Synthese·2026
Same author

The Challenge of Ignorance Under Scrutiny: Response to Open Peer Commentaries on "Informed Consent Under Ignorance".

The American journal of bioethics : AJOB·2025
Same author

Breaking Up Rationally.

The journal of ethics·2025
Same author

Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited?

International review of psychiatry (Abingdon, England)·2025
Same author

Same Same but Different: On Psychedelic Exceptionalism.

The American journal of bioethics : AJOB·2025
Same author

The Hopkins-Oxford Psychedelics Ethics (HOPE) Working Group Consensus Statement.

The American journal of bioethics : AJOB·2024
Same journal

Sentience. Not Necessarily a Problem?

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same journal

No Need to Feel.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same journal

The One Health Paradigm and Wild Animal Welfare Science.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same journal

From Mollusks to Machines: An Ethical Framework Focused on the Urgency of Extreme Suffering.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same journal

Sentience and Why It Matters.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same journal

The Wrong Motives for Potentially Harming a Being.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.8K

How to Make Psychedelic-Assisted Therapy Safer.

Daniel Villiger1,2

  • 1Uehiro Oxford Institute, University of Oxford, Oxford, UK.

Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees
|December 2, 2024
PubMed
Summary
This summary is machine-generated.

Psychedelic-assisted therapy requires careful patient preparation due to the vulnerability created by psychedelic states. Bringing a trusted person to sessions is a highly effective, overlooked safety measure.

Keywords:
Psychedelic-assisted therapyethicsimpaired autonomysafety measuresvulnerability

More Related Videos

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.3K
Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

3.9K

Related Experiment Videos

Last Updated: Jun 6, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.8K
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.3K
Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

3.9K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • Clinical revival of classic serotonergic psychedelics necessitates ethical considerations for psychedelic-assisted therapy.
  • Patient vulnerability during psychedelic states is a key ethical concern requiring robust safety protocols.

Purpose of the Study:

  • To examine the nature of patient vulnerability induced by psychedelics, specifically the impairment of autonomy.
  • To analyze the strengths and weaknesses of existing safety measures for psychedelic-assisted therapy.
  • To propose an overlooked yet effective safety measure for psychedelic sessions.

Main Methods:

  • Conceptual analysis of psychedelic-induced vulnerability, focusing on diminished decision-making, controllability, and resistance to influence.
  • Systematic evaluation of five proposed safety measures in the literature.
  • Identification and proposal of a novel safety intervention.

Main Results:

  • Psychedelic-induced vulnerability stems from impaired autonomy, affecting decision-making, control, and external influence resistance.
  • Preparatory sessions, advance directives, and training/oversight are beneficial safety measures.
  • Lowering dosage and omitting therapy are less effective safety strategies.

Conclusions:

  • Optimizing safety in psychedelic therapy involves understanding and mitigating autonomy impairments.
  • Existing safety measures can be enhanced, and novel strategies, like including a trusted companion, should be considered.
  • Integrating a close person into psychedelic sessions offers a feasible and effective safety enhancement.